407 related articles for article (PubMed ID: 12015982)
21. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
22. Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland.
Bull JJ; Pelengaris S; Hendrix S; Chronnell CM; Khan M; Philpott MP
Br J Dermatol; 2005 Jun; 152(6):1125-33. PubMed ID: 15948972
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induced by droloxifene and C-myc, Bax, Bcl-2 protein expression in corpus luteum of pregnant rats.
Leng Y; Gu ZP; Cao L
Acta Pharmacol Sin; 2001 Apr; 22(4):327-34. PubMed ID: 11742585
[TBL] [Abstract][Full Text] [Related]
24. Cooperative interaction between c-myc and bcl-2 proto-oncogenes.
Fanidi A; Harrington EA; Evan GI
Nature; 1992 Oct; 359(6395):554-6. PubMed ID: 1406976
[TBL] [Abstract][Full Text] [Related]
25. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.
Pelengaris S; Khan M
Expert Opin Ther Targets; 2003 Oct; 7(5):623-42. PubMed ID: 14498825
[TBL] [Abstract][Full Text] [Related]
26. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
27. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
Wang Y; Szekely L; Okan I; Klein G; Wiman KG
Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
[TBL] [Abstract][Full Text] [Related]
28. MYC and the control of apoptosis.
McMahon SB
Cold Spring Harb Perspect Med; 2014 Jul; 4(7):a014407. PubMed ID: 24985130
[TBL] [Abstract][Full Text] [Related]
29. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
[TBL] [Abstract][Full Text] [Related]
30. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
31. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
[TBL] [Abstract][Full Text] [Related]
32. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
Hueber AO; Bösser S; Zörnig M
Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
34. An in vitro model of the early genetic events in multistage carcinogenesis of malignant insulinoma.
Katić M; Hadzija M; Wrischer M; Pavelić K
Carcinogenesis; 1999 Aug; 20(8):1521-7. PubMed ID: 10426801
[TBL] [Abstract][Full Text] [Related]
35. c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells.
Demeterco C; Itkin-Ansari P; Tyrberg B; Ford LP; Jarvis RA; Levine F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3475-85. PubMed ID: 12107268
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
Eischen CM; Woo D; Roussel MF; Cleveland JL
Mol Cell Biol; 2001 Aug; 21(15):5063-70. PubMed ID: 11438662
[TBL] [Abstract][Full Text] [Related]
37. Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation.
Radziszewska A; Schroer SA; Choi D; Tajmir P; Radulovich N; Ho JC; Wang L; Liadis N; Hakem R; Tsao MS; Penn LZ; Evan GI; Woo M
J Biol Chem; 2009 Apr; 284(16):10947-56. PubMed ID: 19213729
[TBL] [Abstract][Full Text] [Related]
38. Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro.
Rudolph B; Hueber AO; Evan GI
Oncogene; 2000 Apr; 19(15):1891-900. PubMed ID: 10773879
[TBL] [Abstract][Full Text] [Related]
39. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus.
Zheng X; Hendry WJ
Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088
[TBL] [Abstract][Full Text] [Related]
40. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
Osanai M; Ogawa K; Lee GH
Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
